3 Managing Disease Activity During Treatment with Natalizumab in Relapsing-Remitting Multiple Sclerosis
Nathaniel Lizak,Sifat Sharmin,Dana Horakova,Eva Havrdova,Guillermo Izquierdo Ayuso,Sara Eichau Madueno,Anneke van der Walt,Helmut Butzkueven,Jeannette Lechner-Scott,Katherine Buzzard,Olga Skibina,O. Gerlach,Alexandre Prat,Marc Girard,Pierre Duquette,Raed Alroughani,Francesco Patti,Francois Grand'Maison,Maria Jose Sa,Eduardo Aguera Morales,Suzanne Hodgkinson,Pierre Grammond,Jens Kuhle,Bassem I. Yamout,Samia Khoury,Serkan Ozakbas,Mark Slee,Tunde Csepany,Nevin A. John,Guy Laureys,Liesbeth Van Hijfte,Murat Terzi,Maria Pia Amato,Cavit Boz,Abdullah Al-Asmi,Elisabetta Cartechini,Riadh Gouider,Saloua Mrabet,Izanne Roos,Tomas Kalincik MULTIPLE SCLEROSIS JOURNAL（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper